Related Experiment Video
Updated: Feb 8, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal
Ishaq A Viringipurampeer1, Cheryl Y Gregory-Evans1, Andrew L Metcalfe1
1Department of Ophthalmology and Visual Sciences, University of British Columbia, 2550 Willow Street, Vancouver, BC, V5Z 3N9, Canada.
Abstract:
Retinitis pigmentosa (RP) is a group of inherited neurological disorders characterized by rod photoreceptor cell death, followed by secondary cone cell death leading to progressive blindness. Currently, there are no viable treatment options for RP. Due to incomplete knowledge of the molecular signaling pathways associated with RP pathogenesis, designing therapeutic strategies remains a challenge. In particular, preventing secondary cone photoreceptor cell loss is a key goal in designing potential therapies. In this study, we identified the main drivers of rod cell death and secondary cone loss in the transgenic S334ter rhodopsin rat model, tested the efficacy of specific cell death inhibitors on retinal function, and compared the effect of combining drugs to target multiple pathways in the S334ter and P23H rhodopsin rat models. The primary driver of early rod cell death in the S334ter model was a caspase-dependent process, whereas cone cell death occurred though RIP3-dependent necroptosis. In comparison, rod cell death in the P23H model was via necroptotic signaling, whereas cone cell loss occurred through inflammasome activation. Combination therapy of four drugs worked better than the individual drugs in the P23H model but not in the S334ter model. These differences imply that treatment modalities need to be tailored for each genotype. Taken together, our data demonstrate that rationally designed genotype-specific drug combinations will be an important requisite to effectively target primary rod cell loss and more importantly secondary cone survival.
Insights
Retinitis pigmentosa (RP) treatments require genotype-specific strategies. Targeting cell death pathways with drug combinations shows promise for preserving vision in RP patients, particularly for cone photoreceptor survival.
Area of Science:
- Ophthalmology
- Neuroscience
- Genetics
Background:
- Retinitis pigmentosa (RP) is an inherited retinal disease causing progressive vision loss due to photoreceptor cell death.
- Current treatments for RP are limited, highlighting the need for novel therapeutic strategies.
- Understanding the molecular mechanisms driving photoreceptor cell death is crucial for developing effective interventions.
Purpose of the Study:
- To identify the molecular drivers of rod and cone cell death in two distinct RP rat models (S334ter and P23H rhodopsin).
- To evaluate the efficacy of single and combination drug therapies targeting cell death pathways.
- To determine if genotype-specific treatments are necessary for RP.
Main Methods:
- Utilized transgenic S334ter and P23H rhodopsin rat models of retinitis pigmentosa.
- Investigated cell death mechanisms including caspase-dependent apoptosis and RIP3-dependent necroptosis.
- Administered specific cell death inhibitors and combination therapies to assess retinal function and cell survival.
Main Results:
- In the S334ter model, rod death was caspase-dependent, while cone death involved necroptosis.
- In the P23H model, rod death was necroptotic, and cone loss resulted from inflammasome activation.
- Combination therapy improved outcomes in the P23H model but not the S334ter model, indicating genotype-specific responses.
Conclusions:
- Different RP genotypes utilize distinct cell death pathways.
- Genotype-specific combination therapies are essential for effectively treating RP and preserving cone photoreceptor survival.
- Tailored therapeutic approaches are critical for managing inherited retinal degenerations.
More Related Videos
Related Concept Videos
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell Specific Gene Expression
Cell Specific Gene Expression
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

